Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kikuo Sugimoto is active.

Publication


Featured researches published by Kikuo Sugimoto.


European Journal of Pharmacology | 1996

Suppressive effect of N-(benzyloxycarbonyl)-L-phenylalanyl-L-tyrosinal on bone resorption in vitro and in vivo

Je-Tae Woo; Kohji Yamaguchi; Takahiro Hayama; Takeo Kobori; Sanae Sigeizumi; Kikuo Sugimoto; Kiyosi Kondo; Tomoko Tsuji; Yasuo Ohba; Kahori Tagami; Koji Sumitani

The suppressive effect of N-(benzyloxycarbonyl)-L-phenylalanyl-L-tyrosinal on bone resorption was examined in vitro and in vivo. This synthetic peptidyl aldehyde was found to be a potent and selective cathepsin L inhibitor in our screening for cysteine protease inhibitors. In the pit formation assay with unfractionated rat bone cells, 1.5 nM of this compound markedly inhibited parathyroid hormone-stimulated osteoclastic bone resorption. In addition, intraperitoneal administration of this peptidyl aldehyde (2.5-10 mg/kg) for 4 weeks suppressed bone weight loss dose dependently in the ovariectomized mouse, experimental model of osteoporosis. Hydroxyproline measurement of the decalcified femurs from these ovariectomized mice suggested that this compound acts as a bone resorption suppressor through the inhibition of collagen degradation.


Bioorganic & Medicinal Chemistry Letters | 1995

Peptidyl aldehyde derivatives as potent and selective inhibitors of cathepsin L

Je-Tae Woo; Sanae Sigeizumi; Kohji Yamaguchi; Kikuo Sugimoto; Takeo Kobori; Tomoko Tsuji; Kiyosi Kondo

Abstract A series of peptidyl aldehyde derivatives were synthesized and tested for their inhibitory effects on several cysteine proteases and a serine protease. These componds showed no inhibition for α-chymotrypsin at the concentration less than 1000 ng/ml, while they exhibited prominent inhibition for calpain II and cathepsins, especially cathepsin L.


Bioorganic & Medicinal Chemistry Letters | 2003

Sphingomyelin analogues as inhibitors of sphingomyelinase.

Minoru Taguchi; Kikuo Sugimoto; Kenichi Goda; Tomoko Akama; Kyoko Yamamoto; Taizo Suzuki; Yasumitsu Tomishima; Mariko Nishiguchi; Koshi Arai; Kenzo Takahashi; Takeo Kobori

To search for neutral sphingomyelinase inhibitors we designed and synthesized hydrolytically stable analogues of sphingomyelin. The novel compounds 8 and 9 which were replaced the phosphodiester moiety of sphingomyelin with the carbamate moiety showed inhibitory activity with an IC(50) value of micro M on neutral sphingomyelinase in rat brain microsomes. Compound 8i showed a selective neutral sphingomyelinase inhibitory activity.


Tetrahedron Letters | 1994

A new selective dichlorination of CC double bonds

Kunikazu Sakai; Kikuo Sugimoto; Sanae Shigeizumi; Kiyosi Kondo

Abstract A new dichlorination procedure of CC double bond was developed with hexachloroethane as chlorinating agent and RuCl2(PPh3)3 as catalyst. The reaction is highly selective for CC double bond; other functional groups are unaffected by these conditions.


Journal of Applied Polymer Science | 1991

Chemical modification of poly(substituted-acetylene). VI, Introduction of fluoroalkyl group into poly(1-trimethylsilyl-1-propyne) and the improved ethanol permselectivity at pervaporation

Yu Nagase; Kikuo Sugimoto; Yuriko Takamura; Kiyohide Matsui


Journal of Applied Polymer Science | 1986

Novel anion exchange membranes having fluorocarbon backbone: Preparation and stability

Kiyohide Matsui; Etsuko Tobita; Kikuo Sugimoto; Kiyosi Kondo; Toru Seita; Akira Akimoto


Bioorganic & Medicinal Chemistry Letters | 2003

Biological evaluation of sphingomyelin analogues as inhibitors of sphingomyelinase.

Minoru Taguchi; Kenichi Goda; Kikuo Sugimoto; Tomoko Akama; Kyoko Yamamoto; Taizo Suzuki; Yasumitsu Tomishima; Mariko Nishiguchi; Koshi Arai; Kenzo Takahashi; Takeo Kobori


Pesticide Science | 1980

Stereochemical and chiral aspects in the synthesis of 3-(2,2- dihalovinyl)-2,2-dimethylcyclopropanecarboxylic acids†

Kiyosi Kondo; Toshiyuki Takashima; Akira Negishi; Kiyohide Matsui; Tamotsu Fujimoto; Kikuo Sugimoto; Charles E. Hatch; Jonathan S. Baum


Archive | 1996

Peptide derivatives and angiotensin iv receptor agonist

Kenichi Goda; Takeo Kobori; Kikuo Sugimoto


Archive | 1979

PROCESS FOR PREPARING HIGH CIS 3-(2,2,2-TRICHLOROETHYL)-2,2-DIMETHYLCYCLOPROPANE-1-CARBOXYLATES

Kiyoshi Kondo; Akira Negishi; Kikuo Sugimoto

Collaboration


Dive into the Kikuo Sugimoto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takeo Kobori

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Kenichi Goda

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Minoru Taguchi

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kenzo Takahashi

Taisho Pharmaceutical Co.

View shared research outputs
Researchain Logo
Decentralizing Knowledge